Targeted nanoparticles assembled via complexation of boronic-acid- containing targeting moieties to diol-containing polymers

Bioconjugate Chemistry

Volumn 24, Issue 4, 2013, Pages 669-677

  Han, Han ^a   Davis, Mark E ^a  

^a California Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BIOCOMPATIBILITY; CONTROLLED DRUG DELIVERY; NANOPARTICLES; POLYETHYLENE OXIDES; TARGETED DRUG DELIVERY;

ANTICANCER DRUG; BORONIC ACID; CAMPTOTHECINS; HERCEPTIN; HYDROPHILIC COPOLYMERS; MUCIC ACIDS; NANOSCALED; SOLID CANCER; TARGETED NANOPARTICLE; TARGETING CAPABILITY;

POLYETHYLENE GLYCOLS;

BORONIC ACID DERIVATIVE; CAMPTOTHECIN; COPOLYMER; MACROGOL; MUCIC ACID; TRASTUZUMAB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL TRANSPORT; CHEMICAL ANALYSIS; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; DRUG TARGETING; HYDROLYSIS; HYDROPHILICITY; IN VITRO STUDY; MOUSE; NONHUMAN; ZETA POTENTIAL;

MUS;

EID: 84876486701     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300640j     Document Type: Article

References (20)

1. Davis, M. E., Chen, Z., and Shin, D. M. (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discovery 7, 771-782
2. Kamaly, N., Xiao, Z. Y., Valencia, P. M., Radovic-Moreno, A. F., and Farokhzad, O. C. (2012) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation Chem. Soc. Rev. 41, 2971-3010
3. Maeda, H., Wu, J., Sawa, T., Matsumura, Y., and Hori, K. (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Controlled Release 65, 271-284
4. Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K. L., Nielsen, U. B., Marks, J. D., Benz, C. C., and Park, J. W. (2006) Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66, 6732-6740
5. Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., and Davis, M. E. (2007) Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging Proc. Natl. Acad. Sci. U.S.A. 104, 15549-15554
6. Choi, C. H. J., Alabi, C. A., Webster, P., and Davis, M. E. (2010) Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles Proc. Natl. Acad. Sci. U.S.A. 107, 1235-1240
7. Davis, M. E. (2009) Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin Adv. Drug Delivery Rev. 61, 1189-1192
8. Davis, M. E. (2009) The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic Mol. Pharmaceutics 6, 659-668
9. Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., and Ribas, A. (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464, 1067-U140
10. Yang, W. Q., Gao, X. M., and Wang, B. H. (2003) Boronic acid compounds as potential pharmaceutical agents Med. Res. Rev. 23, 346-368
11. Chen, W. X., Cheng, Y. F., and Wang, B. H. (2012) Dual-responsive boronate crosslinked micelles for targeted drug delivery Angew. Chem., Int. Ed. 51, 5293-5295
12. Li, Y. P., Xiao, W. W., Xiao, K., Berti, L., Luo, J. T., Tseng, H. P., Fung, G., and Lam, K. S. (2012) Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols Angew. Chem., Int. Ed. 51, 2864-2869
13. Alabi, C. A. and Davis, M. E. U.S. Patent Appl. 20100040556.
14. Cheng, J. J., Khin, K. T., Jensen, G. S., Liu, A. J., and Davis, M. E. (2003) Synthesis of linear, beta-cyclodextrin-based polymers and their camptothecin conjugates Bioconjugate Chem. 14, 1007-1017
15. Springsteen, G. and Wang, B. H. (2002) A detailed examination of boronic acid-diol complexation Tetrahedron 58, 5291-5300
16. Zhao, H., Lee, C., Sai, P. K., Choe, Y. H., Boro, M., Pendri, A., Guan, S. Y., and Greenwald, R. B. (2000) 20-O-acylcamptothecin derivatives: Evidence for lactone stabilization J. Org. Chem. 65, 4601-4606
17. Wiig, H., Gyenge, C. C., and Tenstad, O. (2005) The interstitial distribution of macromolecules in rat tumours is influenced by the negatively charged matrix components J. Physiology (London) 567, 557-567
18. Phillips, G. D. L., Li, G., Dugger, D. L., Crocker, L. M., Parsons, K. L., Mai, E., Blättler, W. A., Lambert, J. M., Chari, R. V. J., Lutz, R. J., Wong, W. L. T., Jacobson, F. S., Koeppen, H., Schwall, R. H., Kenkare-Mitra, S. R., and Sliwkowski, M. X. (2008) Targeting HER2-positive breast cancer with Trastuzumab-DM1, an antibody-cytotoxic drug conjugate Cancer Res. 68, 9280-9290
19. Supko, J. G. and Malspeis, L. (1993) Pharmacokinetics of the 9-amino and 10,11-methylenedioxy derivatives of camptothecin in mice Cancer Res. 53, 3062-3069
20. Han, H. and Davis, M. E. (2013) Single antibody, targeted nanoparticle delivery of camptothecin. submitted.